Fulcrum Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Fulcrum Capital’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,750	Closed	-$203K	–	77
2019 Q3	$203K	Hold	10,750	–	–	0.07%	74
2019 Q2	$127K	Buy	+10,750	New	+$130K	0.05%	60

Fulcrum Capital's ALDR Position: Q4 2019 in Review

Fulcrum Capital sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 10,750 shares — an estimated $203K sold.

Fulcrum Capital first reported a position in ALDR in Q2 2019 and held it in 2 quarters. The position peaked at $203K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Fulcrum Capital reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Fulcrum Capital sold 10,750 Alder Biopharmaceuticals shares in Q4 2019, an estimated $203K.
Fulcrum Capital first reported a position in Alder Biopharmaceuticals in Q2 2019 and held it in 2 quarters.
Fulcrum Capital's Alder Biopharmaceuticals position peaked at $203K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Fulcrum Capital's 13F filing for Q4 2019, filed 3 Feb 2020.